Recent Trends in Pharmaceutical R & D

Dubashynskaya,Petrova,Skorik
DOI: https://doi.org/10.3390/ijms25105359
IF: 5.6
2024-05-15
International Journal of Molecular Sciences
Abstract:Oromucosal drug delivery, both local and transmucosal (buccal), is an effective alternative to traditional oral and parenteral dosage forms because it increases drug bioavailability and reduces systemic drug toxicity. The oral mucosa has a good blood supply, which ensures that drug molecules enter the systemic circulation directly, avoiding drug metabolism during the first passage through the liver. At the same time, the mucosa has a number of barriers, including mucus, epithelium, enzymes, and immunocompetent cells, that are designed to prevent the entry of foreign substances into the body, which also complicates the absorption of drugs. The development of oromucosal drug delivery systems based on mucoadhesive biopolymers and their derivatives (especially thiolated and catecholated derivatives) is a promising strategy for the pharmaceutical development of safe and effective dosage forms. Solid, semi-solid and liquid pharmaceutical formulations based on biopolymers have several advantageous properties, such as prolonged residence time on the mucosa due to high mucoadhesion, unidirectional and modified drug release capabilities, and enhanced drug permeability. Biopolymers are non-toxic, biocompatible, biodegradable and may possess intrinsic bioactivity. A rational approach to the design of oromucosal delivery systems requires an understanding of both the anatomy/physiology of the oral mucosa and the physicochemical and biopharmaceutical properties of the drug molecule/biopolymer, as presented in this review. This review summarizes the advances in the pharmaceutical development of mucoadhesive oromucosal dosage forms (e.g., patches, buccal tablets, and hydrogel systems), including nanotechnology-based biopolymer nanoparticle delivery systems (e.g., solid lipid particles, liposomes, biopolymer polyelectrolyte particles, hybrid nanoparticles, etc.).
biochemistry & molecular biology,chemistry, multidisciplinary
What problem does this paper attempt to address?
The main problem that this paper attempts to solve is to improve the effectiveness and safety of oromucosal drug delivery systems. Specifically, the author focuses on how to design new oromucosal drug delivery systems by using biopolymers with high adhesiveness and their derivatives (such as thiolated and catechol - derivatized derivatives) to improve the bioavailability of drugs and reduce systemic toxicity. These biopolymers can provide an extended drug residence time, unidirectional or modified drug - release capabilities, and enhanced drug permeability, thereby achieving more effective local or transmucosal (buccal) drug delivery. In addition, this paper also explores how to overcome various physiological barriers in the oral mucosa, including mucus, epithelium, enzymes, and immune cells, which limit drug absorption. By summarizing the current research progress, this paper aims to provide a basis for researchers to identify research gaps and potential research areas and promote the development of innovative drug - delivery technologies.